http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2131261-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bea13a46cc546887cf5f9b729f5c9a2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016 |
| filingDate | 1998-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1552d531ef08a20073ab707311a2cc07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0385bd40491057c924445e999d715af0 |
| publicationDate | 1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2131261-C1 |
| titleOfInvention | Preparation for treatment of patients with disbacteriosis and gastroenteric diseases |
| abstract | FIELD: medicine, gastroenterology, pharmacy. SUBSTANCE: invention proposes the preparation that comprises an alkaline hydrolytic lignin, lactulose and bifidobacterium culture taken at the definite ratio. The preparation gives positive results in treatment of patients with disbacteriosis, oncological and allergic diseases, lipid metabolism disorder, viral and chronic hepatitis and metabolic toxicosis of any etiology. EFFECT: enhanced effectiveness. 1 cl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2481413-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2481413-A4 |
| priorityDate | 1998-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.